Updated: 23rd March 2022

Amplifying Data Science Tools for End-to-End eClinical Solutions

< 1 min read By Léa Blaszczynski

On December 7th, Andreas Weber, Group CEO at EvidentIQ, sat down with Natalie Yeadon, Co-Founder & CEO at Impetus Digital to discuss hybrid vs. fully decentralized trials, the use of real-world evidence (RWE) in clinical trials, and how an end-to-end eClinical solution can help meet increasing customer demand across clinical operations and clinical data management, plus much more!

This live session was organized by Impetus Digital, the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight synthesis. You can watch the full webinar by clicking below or listen to the podcast version if you’re on the go.

 
Share This Post

RELATED ARTICLES

10 Tips & Tricks to Optimize Data Capture ...

Want to save time and enhance your clinical trials? Learn how to take your data ...

Learn More

Innovative Real-World-Evidence generation to efficiently combine digital biomarkers ...

How to leverage data linkage to get better outcomes? EvidentIQ, a leading clinical data science ...

Learn More

Implementing a DCT – Decentralized Clinical Trial: the ...

How to leverage both patient centricity and digital innovation in clinical research? Over the past ...

Learn More

Get a Demo

Let us show you how we can help you and your business

Schedule a Meeting

Let’s start a new project together

Get a Quote

Discover a solution tailored to your needs